Bio-Images Research

Howard Stevens

Professor Howard Stevens is a pharmacist whose career spans over three decades during which he has worked in the UK and Europe with companies ranging from large multinational pharmaceutical companies to drug delivery companies, in a variety of positions from bench scientist to board-level Director. After 25 years service to the pharmaceutical industry, he joined academia as a visiting professor in 1995 and in 1998 was appointed to the Pfizer Chair in Exploratory Drug Delivery at the University of Strathclyde. He currently serves as Chairman of the Board of Bio-Images Research Ltd. He is a Fellow of the RPSGB and the RSC and was elected Chairman of the Academy of Pharmaceutical Sciences of GB in October 2001.

Professor Clive Wilson's research has focused on the utilisation of imaging techniques in studying the behaviour of formulations in man. Together with colleagues at Queen's Medical Centre, Nottingham he was one of the pioneers in the application of scintigraphic imaging techniques in drug research, and has received the Amersham and Pfizer awards in recognition of this work.  His current areas of interest are split evenly between drug delivery to the eye and the transit: absorption relationship in oral drug formulation. He has supervised more than fifty Ph.D. students and has authored over 400 research papers, book chapters and reviews. The publications reflect his interest in imaging, physiology, physics, drug metabolism and pharmacokinetics.  He is on the editorial boards of the European Journal of Pharmaceutics & Biopharmaceutics, the AAPS Journal of Pharmaceutical Technology and the Controlled Release Society publications committee.  In addition to his role at Bio-Images, Professor Wilson is J P Todd Professor of Pharmaceutics at Strathclyde.  He is on the scientific advisory boards of six companies in the USA, India, Denmark and Israel and in 2005, received the GSK International Achievement award.  He was the Science chairman of the Royal Pharmaceutical Conference in 2007 and is currently a member of the steering committee of the EUFEPS Bioavailability & Biopharmaceutics group.


Clive Wilson